Month: October 2017

#ACT: Medical Marijuana Could Be On The Line

Protections for the medical marijuana markets that are now legal in 30 states are set to expire on December 8th. After that, over 2 million registered patients’ continued access to their medication will rely on the prohibitionist whims of Attorney General Jeff Sessions, who has been lobbying aggressively for the ability to use the full force of the Justice Department to interfere with their operations.

Setting the Record Straight

One of NORML’s primary missions is to move public opinion sufficiently to legalize the responsible use of marijuana by adults. One of the ways we successfully achieve this goal is by debunking marijuana myths and half-truths via the publication of timely op-eds in online and print media.

Study: Cannabis Use Inversely Associated With Fatty Liver Disease

Adults with a history of cannabis use are less likely to suffer from non-alcoholic fatty liver disease (NAFLD) than are those who have not used the substance, according to data published online in the journal PLoS One. “Active marijuana use provided a protective effect against NAFLD independent of known metabolic risk factors,” authors determined. “[W]e conclude that current marijuana use may favorably impact the pathogenesis of NAFLD in US adults.”

The opioid ‘crisis’

In Scientific American: People Are Dying Because of Ignorance, not Because of Opioids by Carl L. Hart

I am concerned that declaring the opioid crisis a national emergency will serve primarily to increase law-enforcement budgets, precipitating an escalation of this same sort of routine racial discrimination. […]

It is certainly possible to die from an […]